Recombinant Vaccines Market - Novel Pathogen Targeting and Global Health Impact
Market Overview The recombinant vaccines market is experiencing disease diversity emphasis where emerging pathogens, tropical disease targeting, and global health focus drive vaccine development and market expansion. The recombinant vaccines market is projected to exceed USD 18.4 billion through 2030, with disease emphasis driven by pandemic prevention, global health need, and disease burden....
0 Commentarios 0 Acciones 2 Views 0 Vista previa